The Massachusetts-based company claims that Pfizer and BioNTech lifted two key pieces of its mRNA vaccine platform without proper compensation.
Thousands of people in the U.S. and Europe will receive a shot developed partly by Pfizer, designed to protect against the tickborne illness.
Second covid-19 boosters for the general population are reportedly being postponed in favor of new and improved shots.
The U.S. reported 196,230 new cases and 693 deaths on Wednesday.
Affinivax's latest vaccine fights pneumonia, meningitis, and bloodstream infections.
The FDA says children between 5 and 11 years old can now receive a third shot of the Pfizer vaccine.
A shortage of injectable naloxone and other systemic issues have left harm reduction advocates struggling to help prevent overdose deaths.
No other covid-19 vaccine is currently authorized for use in children younger than six years old.
The U.S. has seen a decline in cases but nobody knows how long that will last.
The man also sold unapproved "cancer vaccines" for years.
An annual covid-19 vaccination in the same vein as the yearly flu vaccine is also being reviewed.
The FDA will likely wait until early April to consider authorizing a three-dose series of the vaccine for this age group.
The authorization could be official by the end of February.
Employees will be required to show proof that they’ve gotten their booster shot or take an antigen test to enter Apple premises.
Dave Bateman sent an anti-Semitic screed to dozens of prominent figures in the Silicon Slopes, including the governor.
A low-cost, effective vaccine authorized for use in India this week could soon be shared around the world.
I’ve seen things you people wouldn’t believe. The Capitol riot. I watched NFTs glitter in the dark. All those moments will be lost in time, like tears in rain.
The agency also issued new recommendations for individuals who have been exposed to covid-19, though those are a bit more complicated.
In clinical trials, Pfizer's Paxlovid reduced the likelihood of severe illness from covid-19 by 88% in high-risk patients.
The setback will delay any potential authorization of the vaccine for younger children until next year, as the company will now test out a three-dose version.
